Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes.

Immunoliposomes composed of hydrogenated soy phosphatidylcholine, cholesterol, methoxypoly(ethylene glycol)-distearoyl phosphatidylethanolamine (mPEG-DSPE), and hydrazide-PEG-DSPE (mole ratio, 57:38:3.3:1.7) linked to periodate-oxidized chimerized mouse IgG (C225, anti-human epidermal growth factor receptor) were prepared by an optimized aggregation-free procedure. The antigen-binding activity of the immunoliposomes was well preserved. When injected intravenously into naive rats, the immunoliposomes (approximately 18 IgG per 100 nm liposome) exhibited long circulation times (MRT = 8.5 h, Cl = 0.2 ml/h). Subsequent injections of the immunoliposomes into the same animals resulted in rapid clearance (MRT < or = 0.7 h, Cl > or = 7 ml/h), which was accompanied by a significant increase in anti-C225 specific titers. Upon repeated injection or coinjection with the parent liposomes free C225 consistently exhibited prolonged circulation without any increase in C225-specific antisera, but was cleared quickly when administered into animals that had been pretreated with the immunoliposomes. Screening of the immunoliposome induced antisera against human polyclonal IgG and C225-derived Fab' fragment revealed that the immune response was specifically triggered by the constant human region of C225. These results demonstrate that the preparations of PEG-grafted immunoliposomes are more immunogenic than the free IgG component, which is of profound importance to the antibody-mediated liposomal drug delivery effort.

[1]  Samuel Zalipsky,et al.  Chemistry of polyethylene glycol conjugates with biologically active molecules , 1995 .

[2]  V. Torchilin,et al.  Poly(ethylene glycol)-coated anti-cardiac myosin immunoliposomes: factors influencing targeted accumulation in the infarcted myocardium. , 1996, Biochimica et biophysica acta.

[3]  T. Allen,et al.  A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. , 1995, Biochimica et biophysica acta.

[4]  D. Davies,et al.  The three-dimensional structure at 6 A resolution of a human gamma Gl immunoglobulin molecule. , 1971, The Journal of biological chemistry.

[5]  G. Storm,et al.  Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. , 1993, Biochimica et biophysica acta.

[6]  M. Woodle,et al.  Sterically stabilized liposomes. , 1992, Biochimica et biophysica acta.

[7]  A. Emili,et al.  Immunogenicity of immunoliposomes. , 1991, Immunology letters.

[8]  S. Zalipsky.  Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes. , 1993, Bioconjugate chemistry.

[9]  F. Szoka,et al.  Antigen presentation by B cells and macrophages of cytochrome c and its antigenic fragment when conjugated to the surface of liposomes. , 1989, Vaccine.

[10]  C. Alving,et al.  Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens. , 1992, Biochimica et biophysica acta.

[11]  M. Maio,et al.  Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells. , 1993, Cancer research.

[12]  John W. Park,et al.  Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. , 1997, Biochemistry.

[13]  N. Phillips,et al.  Immunogenicity of immunoliposomes: reactivity against species-specific IgG and liposomal phospholipids. , 1995, Immunology letters.

[14]  G. Storm,et al.  Immunoliposomes in vivo. , 1994, ImmunoMethods.

[15]  M. Woodle,et al.  Peptide attachment to extremities of liposomal surface grafted PEG chains: preparation of the long-circulating form of laminin pentapeptide, YIGSR. , 1995, Bioconjugate chemistry.

[16]  D. O'Shannessy,et al.  Labeling of the oligosaccharide moieties of immunoglobulins. , 1987, Journal of immunological methods.

[17]  V. Torchilin,et al.  Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. , 1991, Biochimica et biophysica acta.

[18]  N. Phillips,et al.  Immunoliposome targeting to murine CD4+ leucocytes is dependent on immune status. , 1994, Journal of immunology.

[19]  E. Åkerblom,et al.  Immunotherapy with monomethoxypolyethylene glycol modified allergens. , 1990, Critical reviews in therapeutic drug carrier systems.

[20]  Y. Barenholz,et al.  Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. , 1994, Cancer research.

[21]  I. Ahmad,et al.  Antibody-Mediated Targeting of Long-Circulating (StealthR) Liposomes , 1994 .

[22]  M. Woodle,et al.  67Gallium-labeled liposomes with prolonged circulation: preparation and potential as nuclear imaging agents. , 1993, Nuclear medicine and biology.

[23]  T. Allen,et al.  Long-circulating, polyethylene glycol-grafted immunoliposomes , 1996 .

[24]  L. Huang,et al.  Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies. , 1995, Biochimica et biophysica acta.

[25]  K. Matthay,et al.  Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. , 1992, Biochimica et biophysica acta.

[26]  A. Sehon.  Suppression of Antibody Responses by Conjugates of Antigens and Monomethoxypoly(Ethylene Glycol) , 1991 .

[27]  G. Gregoriadis,et al.  Liposomes as immunological adjuvants: antigen incorporation studies. , 1987, Vaccine.

[28]  E. Moase,et al.  Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. , 1995, Biochimica et biophysica acta.

[29]  N. Goldstein,et al.  Isolation and characterization of a monoclonal antibody binding to the extracellular domain of the flk-2 tyrosine kinase receptor. , 1995, Hybridoma.